Drug Utilization Studies in Pregnant Women for Newly Licensed Medicinal Products: A Contribution from IMI ConcePTION.

MLA

Lopez-Leon, Sandra, et al. “Drug Utilization Studies in Pregnant Women for Newly Licensed Medicinal Products: A Contribution from IMI ConcePTION.” Journal of Pregnancy, vol. 2024, Jan. 2024, p. 8862801. EBSCOhost, https://doi.org/10.1155/2024/8862801.

APA

Lopez-Leon, S., Geldhof, A., Scotto, J., Wurst, K., Sabidó, M., Mo, J., Molgaard-Nielsen, D., Bergman, J. E. H., Phi, X. A., & Jordan, S. (2024). Drug Utilization Studies in Pregnant Women for Newly Licensed Medicinal Products: A Contribution from IMI ConcePTION. Journal of Pregnancy, 2024, 8862801. https://doi.org/10.1155/2024/8862801

Chicago

Lopez-Leon, Sandra, Anja Geldhof, Julie Scotto, Keele Wurst, Meritxell Sabidó, Jingping Mo, Ditte Molgaard-Nielsen, Jorieke E H Bergman, Xuan Anh Phi, and Sue Jordan. 2024. “Drug Utilization Studies in Pregnant Women for Newly Licensed Medicinal Products: A Contribution from IMI ConcePTION.” Journal of Pregnancy 2024 (January): 8862801. doi:10.1155/2024/8862801.